Guilhem Solé - Concepedia

Author

Guilhem Solé

Also Known As

Aude Servais, Caroline Barau, Cyril Schweitzer, D Verri, Emmanuelle Salort-Campana, G Sole, G. Sole, G. Solé, G. Solé, Guilhem SOLE

194

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Inserm Centre Hospitalier Universitaire de Bordeaux Hôpital Pellegrin Sorbonne Université Hospices Civils de Lyon

About

Guilhem Solé is an author at Inserm specializing in medicine, pathology, and genetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	1.7K
2	Public Health	2	2	164
3	Engineering	1	1	36
4	Health Sciences	1	1	11
5	Social Sciences	1	1	14

Guilhem Solé

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study James F. Howard, Kimiaki Utsugisawa, Michael Benatar, The Lancet Neurology Multicentre StudyPharmacologyMedicineMyasthenia GravisNeuromuscular Blockade	2017	745
Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies Karim Wahbi, Rabah Ben Yaou, Estelle Gandjbakhch, Circulation	2019	245
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study Vera Bril, Artur Drużdż, Julian Großkreutz, The Lancet Neurology Clinical TrialsGeneralised Myasthenia GravisPharmacotherapyMedicineAnesthesiology	2023	227
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial Jordi Díaz‐Manera, Priya S. Kishnani, Hani Kushlaf, The Lancet Neurology Late-onset Pompe DiseaseAutoimmune DiseaseClinical Infectious DiseaseMedicinePhase 3	2021	169
Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy Stephan Klebe, Christel Depienne, S. Gerber, Brain	2012	165
Thrombocytopenia resulting from mutations in filamin A can be expressed as an isolated syndrome Paquita Nurden, Najet Debili, Isabelle Coupry, Blood	2011	162
Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational Study Céline Dogan, Marie De Antonio, Dalil Hamroun, PLoS ONE	2016	145
<i>SPG15</i> is the second most common cause of hereditary spastic paraplegia with thin corpus callosum Cyril Goizet, A. Boukhris, David Maltête, Neurology	2009	97
REEP1 mutations in SPG31: Frequency, mutational spectrum, and potential association with mitochondrial morpho-functional dysfunction Cyril Goizet, Christel Depienne, Giovanni Bénard, Human Mutation GeneticsMolecular BiologyMolecular GeneticsDisease Gene IdentificationPure Dominant Hsp	2011	95
Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network Guilhem Solé, Emmanuelle Salort‐Campana, Yann Péréon, Revue Neurologique Neuromuscular PatientsVirus EpidemiologyCovid-19 Pandemic OutbreakGlobal Health CrisisCovid-19 Pandemic	2020	84

Page 1